Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Theravance: Still A Buy On Weakness
Seeking Alpha
Sunday, November 4, 2012 - 10:44am
tags:
Theravance
New drug holds promise as therapy for rare and deadly cholesterol disorder
Equities.com
Sunday, November 4, 2012 - 10:43am
tags:
lomitapide, hypercholesterolemia, Aegerion
China Biotech In Review: Charles River Labs Buys China's Vital River
Seeking Alpha
Sunday, November 4, 2012 - 10:30am
tags:
Charles Grassley, Vital River, Guangxi, Guangxi Wuzhou Pharma, Fosun Pharmaceutical, China MediTech, Sihuan Pharmaceutical, Xiamen Innovax Biotech, Innovent Biologics
Arena Looks To Be The Clear Winner In The Weight Loss Space
Seeking Alpha
Sunday, November 4, 2012 - 10:27am
tags:
Arena Pharmaceuticals, Vivus, Qsymia, weight loss, obesity, Belviq
Medicis Pharmaceutical Larger Than S&P 500 Component Pitney Bowes
Forbes
Saturday, November 3, 2012 - 11:45am
tags:
Medicis
Shionogi enters into license agreement with Janssen for Alzheimer's treatment
Equities.com
Saturday, November 3, 2012 - 11:44am
tags:
Shionogi, Janssen Pharmaceuticals, Alzheimer's disease
Merck Settles Vioxx Lawsuit
Daily Finance
Saturday, November 3, 2012 - 11:43am
tags:
Merck, Vioxx, lawsuits
3 Pharmaceutical Stocks to Sell Now
InvestorPlace
Saturday, November 3, 2012 - 11:41am
tags:
Warner Chilcott, Sagent Pharmaceuticals, Pemix Therapeutic Holdings
Ensemble inks $186M deal with Boehringer Ingelheim
Mass High Tech, MA
Saturday, November 3, 2012 - 11:40am
tags:
Ensemble Therapeutics, Boehringer
Valeant profit plummets as acquisition costs pile up
Financial Post, CA
Saturday, November 3, 2012 - 11:39am
tags:
Valeant Pharmaceuticals
Why Investors Are Excited About Dendreon's Earnings
Motley Fool
Saturday, November 3, 2012 - 11:36am
tags:
Dendreon, earnings
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess of $100,000 Investing In Keryx Biopharmaceuticals, Inc. To Contact the Firm
Yahoo/PR Newswire
Saturday, November 3, 2012 - 11:36am
tags:
Keryx, lawsuits
J&J drug wins wider approval for leg and lung clots
Reuters
Saturday, November 3, 2012 - 11:34am
tags:
JNJ, Xarelto, blood clots
Eli Lilly And Company: Today's Featured Drugs Laggard
The Street
Saturday, November 3, 2012 - 11:33am
tags:
Eli Lilly
Lpath Announces Filing of Shelf Registration Statement
Yahoo/MarketWire
Saturday, November 3, 2012 - 11:32am
tags:
Lpath
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, November 3, 2012 - 11:31am
tags:
Abiomed, Lexicon Pharmaceuticals, Corcept Therapeutics
Vertex's Shocking Decline Hurts Investors
Motley Fool
Saturday, November 3, 2012 - 11:30am
tags:
Vertex Pharmaceuticals
Questcor: A Case Mistaken Identity?
Wall Street Cheat Street
Saturday, November 3, 2012 - 11:30am
tags:
Questcor Pharmaceuticals, Acthar
Celgene Corporation: Today's Featured Health Care Laggard
The Street
Saturday, November 3, 2012 - 11:28am
tags:
Celgene Corporation
For Hep C Investors, What Goes Around Comes Around
Motley Fool
Saturday, November 3, 2012 - 11:28am
tags:
hepatitis C, Vertex Pharmaceuticals, Gilead Sciences, Abbott Laboratories, Idenix, Achillion

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.